Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
The current price of MD1.STU is €20.5 EUR — it has increased by +0.49% in the past 24 hours. Watch Medistim ASA stock price performance more closely on the chart.
What is Medistim ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medistim ASA stocks are traded under the ticker MD1.STU.
Is Medistim ASA stock price growing?▼
MD1.STU stock has risen by +7.05% compared to the previous week, the month change is a +9.92% rise, over the last year Medistim ASA has showed a +58.3% increase.
How many employees does Medistim ASA have?▼
As of April 11, 2026, the company has 154 employees.